Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 15.76
-0.08 (-0.51%)
Sep 11, 2026, 5:30 PM CET
SWX:SANN Market Cap
SWX:SANN has a market cap or net worth of 240.73 million as of September 11, 2026. Its market cap has increased by 29.27% in one year.
Market Cap
240.73M
Enterprise Value
267.24M
Revenue
77.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.76
ChartMarket Cap Chart
Since November 3, 2006, SWX:SANN's market cap has decreased from 357.28M to 240.73M, a decrease of -32.62%. That is a compound annual growth rate of -1.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 240.73M | 42.91% |
| Dec 30, 2025 | 168.45M | 0.68% |
| Dec 30, 2024 | 167.31M | 85.24% |
| Dec 29, 2023 | 90.32M | 19.92% |
| Dec 30, 2022 | 75.32M | 34.92% |
| Dec 30, 2021 | 55.82M | 3.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.89B |
| Idorsia | 1.35B |
| Basilea Pharmaceutica AG | 804.70M |
| Newron Pharmaceuticals | 246.34M |
| BioVersys AG | 160.71M |
| Molecular Partners AG | 132.54M |
| Xlife Sciences AG | 83.82M |
| MindMaze Therapeutics Holding | 29.61M |